Patient Square Capital leads $145m financing in debut deal

Apollo's multi-product therapeutic portfolio is a healthcare model Patient Square execs like and know well, with founder Jim Momtazee having invested behind likeminded playbooks at Jazz Pharmaceuticals and BridgBio during his days at KKR.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this